Activities, Bill Numbers and Titles
|
|
Client: Biogen Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $14,700.00
|
Senate Bill
|
736
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
1254
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
756
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
House Bill
|
1089
|
An Act promoting continuity of care for Multiple Sclerosis treatment
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
686
|
An Act promoting continuity of care for multiple sclerosis treatment
|
Support
|
$0.00
|
N/A
|
House Bill
|
1053
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
627
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
House Bill
|
1224
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
644
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
House Bill
|
1311
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
771
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
729
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
12/15/2021 |
House Victory Fund
|
N/A
|
$200.00
|
| | Total contributions |
$200.00
|
|